These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 7471099

  • 1. Resistance patterns of Walker carcinosarcoma 256 and other rodent tumors to cyclophosphamide and L-phenylalanine mustard.
    Schmid FA, Otter GM, Stock CC.
    Cancer Res; 1980 Mar; 40(3):830-3. PubMed ID: 7471099
    [Abstract] [Full Text] [Related]

  • 2. Response of drug-sensitive and -resistant L1210 leukemias to high-dose chemotherapy.
    Griswold DP, Trader MW, Frei E, Peters WP, Wolpert MK, Laster WR.
    Cancer Res; 1987 May 01; 47(9):2323-7. PubMed ID: 3567926
    [Abstract] [Full Text] [Related]

  • 3. Reciprocal cross-resistance in human rhabdomyosarcomas selected in vivo for primary resistance to vincristine and L-phenylalanine mustard.
    Horton JK, Houghton PJ, Houghton JA.
    Cancer Res; 1987 Dec 01; 47(23):6288-93. PubMed ID: 2890432
    [Abstract] [Full Text] [Related]

  • 4. Studies with 2,5-piperazinedione, 3,6-bis(5-chloro-2-piperidyl)-,dihydrochloride. III. Biochemical and therapeutic effects in L1210 leukemias sensitive and resistant to alkylating agents: comparison with melphalan, cyclophosphamide, and BCNU.
    Schabel FM, Trader MW, Laster WR, Shaddix SC, Brockman RW.
    Cancer Treat Rep; 1976 Sep 01; 60(9):1325-33. PubMed ID: 1016968
    [Abstract] [Full Text] [Related]

  • 5. Patterns of resistance and therapeutic synergism among alkylating agents.
    Schabel FM, Trader MW, Laster WR, Wheeler GP, Witt MH.
    Antibiot Chemother (1971); 1978 Sep 01; 23():200-15. PubMed ID: 348078
    [Abstract] [Full Text] [Related]

  • 6. Collateral sensitivity to cross-linking agents exhibited by cultured L1210 cells resistant to oxazaphosphorines.
    Sladek NE, Low JE, Landkamer GJ.
    Cancer Res; 1985 Feb 01; 45(2):625-9. PubMed ID: 3967238
    [Abstract] [Full Text] [Related]

  • 7. cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice.
    Schabel FM, Trader MW, Laster WR, Corbett TH, Griswold DP.
    Cancer Treat Rep; 1979 Feb 01; 63(9-10):1459-73. PubMed ID: 291480
    [Abstract] [Full Text] [Related]

  • 8. Drug sensitivity of methylnitrosourea- and 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea-resistant L1210 lines.
    Schmid FA, Otter GM, Chen CF.
    Cancer Res; 1986 Sep 01; 46(9):4469-71. PubMed ID: 3731103
    [Abstract] [Full Text] [Related]

  • 9. PTT.119, p-F-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met ethoxy HCl, a new chemotherapeutic agent active against drug-resistant tumor cell lines.
    Yagi MJ, Chin SE, Scanlon KJ, Holland JF, Bekesi JG.
    Biochem Pharmacol; 1985 Jul 01; 34(13):2347-54. PubMed ID: 4040366
    [Abstract] [Full Text] [Related]

  • 10. [Cytogenetic characteristics of the leukemia L1210 strain in the development of drug resistance].
    Goncharova SA, Minenkova EA, Fomina MM, Demidova NS.
    Eksp Onkol; 1984 Jul 01; 6(4):38-41. PubMed ID: 6499750
    [Abstract] [Full Text] [Related]

  • 11. Ovarian reticular cell sarcoma of the mouse (M5076) made resistant to cyclophosphamide.
    D'Incalci M, Torti L, Damia G, Erba E, Morasca L, Garattini S.
    Cancer Res; 1983 Dec 01; 43(12 Pt 1):5674-80. PubMed ID: 6357429
    [Abstract] [Full Text] [Related]

  • 12. [Acceleration of growth of transplantable tumors and change in the sensitivity to chemotherapy on administration of creatinine].
    Pukhal'skaia ECh, Platonova GN.
    Biull Eksp Biol Med; 1971 Oct 01; 72(10):82-5. PubMed ID: 5126158
    [No Abstract] [Full Text] [Related]

  • 13. gamma-Glutamyl transpeptidase (gamma-GT) and maintenance of thiol pools in tumor cells resistant to alkylating agents.
    Ahmad S, Okine L, Wood R, Aljian J, Vistica DT.
    J Cell Physiol; 1987 May 01; 131(2):240-6. PubMed ID: 2884224
    [Abstract] [Full Text] [Related]

  • 14. The role of drug transport in resistance to nitrogen mustard and other alkylating agents in L518Y lymphoblsts.
    Goldenberg GJ.
    Cancer Res; 1975 Jul 01; 35(7):1687-92. PubMed ID: 1055634
    [Abstract] [Full Text] [Related]

  • 15. Characterization of cytosolic aldehyde dehydrogenase from cyclophosphamide resistant L1210 cells.
    Russo JE, Hilton J.
    Cancer Res; 1988 Jun 01; 48(11):2963-8. PubMed ID: 3365687
    [Abstract] [Full Text] [Related]

  • 16. Cross-resistance of drug-resistant murine leukemias to deoxyspergualin (NSC 356894) in vivo.
    Harrison SD, Brockman RW, Trader MW, Laster WR, Griswold DP.
    Invest New Drugs; 1987 Dec 01; 5(4):345-51. PubMed ID: 3436739
    [Abstract] [Full Text] [Related]

  • 17. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE, Green SJ, Lew D, Costanzi JJ, Athens JW, Osborne CK, Vaughn CB, Martino S.
    Cancer; 2003 Jan 01; 97(1):21-9. PubMed ID: 12491501
    [Abstract] [Full Text] [Related]

  • 18. Antitumor effect of N alpha-benzyloxycarbonyl-N,N-bis-(2-halogenethyl)-hydrazide derivatives of amino acids.
    Karaivanova MH, Zakhariev SG, Golovinsky EV.
    Neoplasma; 1980 Jan 01; 27(2):137-42. PubMed ID: 7393353
    [Abstract] [Full Text] [Related]

  • 19. Potentiation of the cytotoxic action of melphalan and "activated" cyclophosphamide against cultured tumor cells by centrophenoxine.
    Sladek NE.
    J Pharmacol Exp Ther; 1977 Jan 01; 200(1):17-24. PubMed ID: 319221
    [Abstract] [Full Text] [Related]

  • 20. Acute in vivo resistance in high-dose therapy.
    Teicher BA, Ara G, Keyes SR, Herbst RS, Frei E.
    Clin Cancer Res; 1998 Feb 01; 4(2):483-91. PubMed ID: 9516940
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.